Category Archives:

(Reuters) - Kohl's Corp beat quarterly sales estimates on Thursday as the department store chain, like rival Macy's Inc, benefited from Americans returning to brick-and-mortar stores, following the ro...

By Elizabeth Culliford (Reuters) -Facebook Inc on Thursday launched a test of a new virtual-reality remote work app where users of the company's Oculus Quest 2 headsets can hold meetings as avatar ver...

By David Shepardson WASHINGTON (Reuters) - The Federal Aviation Administration said Thursday it was proposing $531,545 in civil penalties against 34 airline passengers over unruly behavior, bringing i...

(Reuters) -Macy's Inc and Kohl's Corp raised their full-year sales and profit forecasts on Thursday, as U.S. shoppers coming back to stores splurge on perfumes, shoes and apparel with vaccinations hel...

HONG KONG/SHANGHAI (Reuters) -Embattled Chinese property developer Evergrande Group is in talks with smartphone maker Xiaomi and Shenzhen state-backed investment firms as it looks to sell part of a 65...

(Reuters) - Estee Lauder Cos Inc forecast fiscal 2022 net sales largely above estimates on Thursday, encouraged by a rebound in demand for makeup products as people start venturing out following the e...

PEORIA, Ill. — Peoria Firefighters, Public Works, and Police were called to a large gas leak late Wednesday night. Battalion Chief Stephen Rada said crews responded to the 2200 block of North Kn...

By Reuters Staff (Reuters) - COVID-19 vaccine booster shots will be made widely available to Americans starting on Sept. 20, U.S. health officials said, citing data showing diminishing protection from...

SINGAPORE (Reuters) - Singapore will allow quarantine-free entry from next month to travelers from Germany and Brunei who are vaccinated against COVID-19, its aviation regulator said on Thursday, as p...

HONG KONG (Reuters) - The Hong Kong government said on Thursday that it and the Singapore government decided not to further pursue a bilateral air travel bubble due to the differences in the anti-epid...